EUVIMEDOdkrijte EUVIMED
CrossrefInformačná karta

The RAGE gene crucial function in the etiology and consequences of Type I diabetes

Amal A. Mohamed, Mohamed O. Mahmoud, Gamil M. Abdallah, Nada S. Ali, Mona AbdelMotaleb Abdelfatah Hussein, Ibrahim T. Ibrahim

Journal of Medicine in Scientific Research · 2024-01-01 · 7 (2)

DOI: 10.59299/2537-0928.1069 ↗
AbstraktBibliografické údaje

Abstrakt

Type I Diabetes, among the ten greatest causes of mortality worldwide, is estimated to afflict 642 million individuals by 2040. It is an auto-immune illness brought on by an association of environmental and genetic variables. that cause T lymphocytes to destroy insulin-producing β-cells. Its prevalence continues to rise by 3-4% annually worldwide, enhancing the risk of mortality. So, the idea of diabetic kidney disease (DKD) is widely established, and systemic treatment is essential. RAGEs are linked to inflammatory disorders that exist in a variety of TID-related cells; especially T cells. Variations in circulating RAGE concentrations have been linked to a higher chance of developing TID. Furthermore, T cells from at-risk individuals who develop TID have higher RAGE expression, which promotes T-cell cytokine generation. AGEs seemed to be the earliest RAGE ligands discovered, and they may suppressed by nutritional and medical interventions. Pre-diabetes had a higher concentration of AGE, which is a good predictor of TID. It remains increased following TID diagnosis, and it is hypothesized that they are linked to the development and advancement of long-lasting problems including retinopathy, nephropathy, and coronary heart disease. This review will provide a summary of RAGE’s gene structure, describe the biological and pathophysiological activities, and give insight into how it contributes to the start, progression, and management of TID.

Vedomosti, ktoré zodpovedajú vašej práci.

Od bezplatného začiatku cez osobnú rešerš literatúry až po kompletný Research Suite.

Zobraziť tarify →

Sú zahrnuté všetky plné texty vydavateľov?

Nie. Bibliografické záznamy, abstrakty a plné texty sú odlišné typy obsahu. To, či je plný text dostupný, závisí od zdroja, Open Access a vašich existujúcich licencií. Tarif EUVIMED nenahrádza dodatočné práva vydavateľa.

Zobraziť tarify →